Literature DB >> 101012

Prognostic factors in multiple myeloma: a retrospective study using conventional statistical methods and a computer program.

Y Matzner, J Benbassat, A Polliack.   

Abstract

The prognostic significance of age, sex, ethnic origin and various laboratory data was studied retrospectively in 69 patients with multiple myeloma using conventional statistical tests and the multiple regression computerized analysis. The conventional statistical analysis confirmed that age, anemia, uremia, hypoalbuminemia, hyperglobulinemia, hyperuricemia and IgA lambda type myeloma were associated with a poor prognosis. The multiple regression analysis indicated that age and blood urea nitrogen levels were the only variables which significantly affect the survival of patients with multiple myeloma. A correlation was found between blood urea nitrogen levels and other laboratory data of apparent prognostic value. The differences between our results and those of other authors are discussed and it is suggested that they may, in part, be due to the fact that the interplay between the various prognostic variables was not exposed in other studies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101012     DOI: 10.1159/000207722

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  [Analysis of prognostic factors in plasmacytoma].

Authors:  W Gassmann; T Haferlach; N Schmitz; W Kayser; H H Euler; J Drews; H Löffler
Journal:  Klin Wochenschr       Date:  1984-10-01

2.  Prognostic factors and classification in multiple myeloma.

Authors:  J F San Miguel; J Sànchez; M Gonzalez
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

3.  Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma.

Authors:  Alessandro Allegra; Caterina Musolino; Elisabetta Pace; Vanessa Innao; Eleonora Di Salvo; Maria Ferraro; Marco Casciaro; Giovanna Spatari; Gennaro Tartarisco; Andrea Gaetano Allegra; Sebastiano Gangemi
Journal:  Antioxidants (Basel)       Date:  2019-03-04

4.  Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.

Authors: 
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.